Please login or register first to view this content.
Respiratory Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Symdeko Approved to Treat Younger Cystic Fibrosis Patients
Molgradex Misses Primary Endpoint in Alveolar Pulmonary Proteinosis Trial
Pertussis Risk Up for Undervaccinated, Unvaccinated Children
Nucala Approved for Self-Administration Via Autoinjector, Prefilled Safety Syringe
Zerbaxa Approved to Treat Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia
Treatment for Malignant Pleural Mesothelioma Gets FDA Approval
Women With COPD Have Worse QoL, Increased Symptom Burden
Pulmonary Hypertension Survival Predicted by Cardiopulmonary Reserve Index
Budesonide-Formoterol Reliever Therapy Beats Albuterol for Prevention of Asthma Exacerbations
COPD Exacerbation Frequency and Treatment Strategy Differs by GOLD Stage
Obesity Does Not Increase ICU Mortality Rate in Acute Respiratory Failure
PONENTE Trial May Provide Guidance for OCS Tapering in Asthma
Aclidinium Delays COPD Event Onset, Does Not Increase MACE Risk
Factors Affecting Lung Function Improvement With Omalizumab
Mepolizumab and High-Baseline EDN Linked to Lower Asthma Exacerbation Rates
Switching and Combining Biologics for the Treatment of Severe Asthma
Moderate to Acute Asthma Benefits From Maintenance and Reliever Therapy
In 2015 to 2016, 45.8 Percent of US Population Used Rx Drugs
